Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser and Topical Clonazepam for Burning Mouth Syndrome
NCT04313907Phase 4Unknown
- Sponsor
- Universidad Nacional Autónoma de México
- Start
- Aug 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clonazepam in burning mouth syndrome (BMS), sponsored by Universidad Nacional Autónoma de México. Status: unknown.
02
Drugs
clonazepam
03
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT04313907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04313907.